孕妇肠道菌群与产前抑郁之间的关联性及血浆色氨酸的潜在中介作用(英文)

臧恬滋 ,  韦仪 ,  范肖肖 ,  谢田瞿 ,  刘燕群

中南大学学报(医学版) ›› 2025, Vol. 50 ›› Issue (12) : 2226 -2240.

PDF (2871KB)
中南大学学报(医学版) ›› 2025, Vol. 50 ›› Issue (12) : 2226 -2240. DOI: 10.11817/j.issn.1672-7347.2025.250498
女性全生命周期心理健康专题

孕妇肠道菌群与产前抑郁之间的关联性及血浆色氨酸的潜在中介作用(英文)

作者信息 +

Association of maternal gut microbiota with prenatal depression and the potential mediation effect by plasma tryptophan

Author information +
文章历史 +
PDF (2939K)

摘要

目的 产前抑郁是孕妇在怀孕期间最常见的心理障碍之一,在中国发生率约为19.7%,且发生率呈显著上升趋势。产前抑郁严重危害母婴健康,可引起自伤、自杀,而且持续影响子代的健康。有研究表明肠道菌群失衡及肠-脑轴紊乱会影响大脑功能和行为,在抑郁的发生和发展中起重要作用。孕妇孕期的肠道菌群会发生显著变化,可能对炎症、代谢等方面产生影响。肠道菌群在色氨酸代谢中扮演关键角色,但孕妇肠道菌群调节色氨酸代谢影响大脑功能和情绪的机制尚未完全阐明。本研究旨在基于肠-脑轴机制阐明血浆色氨酸在孕妇肠道菌群与产前抑郁关联中的作用。 方法 共纳入73名孕妇进行研究,采用爱丁堡产后抑郁量表(Edinburgh Postpartum Depression Scale,EPDS)对孕妇进行评估,根据评分分界值(10分)将其分为产前抑郁组(产前抑郁的孕妇)及对照组(无产前抑郁的孕妇)。收集研究对象的相关人口统计信息、粪便和血浆样本。肠道菌群测序使用了16S核糖体RNA(ribosomal RNA,rRNA)测序,血浆和粪便的氨基酸检测使用了超高效液相色谱-电喷雾电离串联质谱分析(ultrahigh performance liquid chromatography-electrospray ionization tandem mass spectrometry,UHPLC-ESI-MS/MS)技术。采用SPSS 26.0和R软件进行数据分析,使用SPSS PROCESS进行中介模型分析。 结果 2组间肠道微生物群的α多样性和β多样性差异均无统计学意义(均P>0.05)。与对照组相比,产前抑郁组的血浆色氨酸含量显著升高(t=-2.964,P<0.05)。Candidatus_Soleaferrea (β=-19.945,OR<0.001,95% CI <0.001~0.002,P=0.004)和Enterococcus (β=-9.074,OR<0.001,95% CI <0.001~0.183,P=0.016)的丰度与产前抑郁均呈负相关,而Lachnospiraceae_NC2004_group的丰度与产前抑郁呈正相关(β=5.870,OR=354.354,95% CI 1.248~100 619.527,P=0.042)。血浆色氨酸水平在Enterococcus和产前抑郁之间起中介作用。 结论 孕期的抑郁症状与孕期肠道菌群的组成有关,而色氨酸作为5-羟色胺的前体物质,可能在这一过程中起中介作用,为今后通过肠道菌群或色氨酸代谢干预改善产前抑郁提供新思路。

Abstract

Objective Prenatal depression is one of the most common psychological disorders during pregnancy, with an incidence of approximately 19.7% in China, and the incidence is showing a significant upward trend. Prenatal depression seriously endangers maternal and infant health, may lead to self-injury and suicide, and has lasting effects on the health of offspring. Studies have shown that gut microbiota imbalance and disruption of the gut-brain axis can affect brain function and behavior and play an important role in the occurrence and development of depression. Significant changes occur in the gut microbiota of pregnant women during pregnancy, which may influence inflammation and metabolism. Gut microbiota play a key role in tryptophan metabolism; however, the mechanisms by which maternal gut microbiota regulate tryptophan metabolism to affect brain function and mood remain unclear. This study aims to clarify the role of plasma tryptophan in the relationship between gut microbiota and prenatal depression in pregnant women based on the gut-brain axis mechanism. Methods A total of 73 pregnant women were included in the study. The Edinburgh Postnatal Depression Scale (EPDS) was used for assessment. According to the cutoff score (10 points), participants were divided into a prenatal depression group (pregnant women with prenatal depression) and a control group (pregnant women without prenatal depression). Demographic information, fecal samples, and plasma samples were collected. Gut microbiota sequencing was performed using 16S ribosomal RNA (rRNA) sequencing. Amino acid detection in plasma and feces was conducted using ultrahigh performance liquid chromatography-electrospray ionization tandem mass spectrometry (UHPLC-ESI-MS/MS). Data were analyzed using SPSS 26.0 and R software, and mediation model analysis was performed using SPSS PROCESS. Results There were no statistically significant differences in α-diversity or β-diversity of gut microbiota between the 2 groups (all P>0.05). Compared with the control group, plasma tryptophan levels were significantly higher in the prenatal depression group (t=-2.964, P<0.05). The abundances of Candidatus_Soleaferrea (β=-19.945, OR<0.001, 95% CI <0.001 to 0.002, P=0.004) and Enterococcus (β=-9.074, OR<0.001, 95% CI <0.001 to 0.183, P=0.016) were negatively correlated with prenatal depression, whereas the abundance of Lachnospiraceae_NC2004_group was positively correlated with prenatal depression (β=5.870, OR=354.354, 95% CI 1.248 to 100 619.527, P=0.042). Plasma tryptophan levels played a mediating role between Enterococcus abundance and prenatal depression. Conclusion Depressive symptoms during pregnancy are associated with the composition of gut microbiota during pregnancy. Tryptophan, as a precursor of serotonin, may play a mediating role in this process, providing new insights for improving prenatal depression through interventions targeting gut microbiota or tryptophan metabolism.

Graphical abstract

关键词

肠道菌群 / 产前抑郁 / 肠-脑轴 / 色氨酸 / 妊娠

Key words

gut microbiota / prenatal depression / gut-brain axis / tryptophan / pregnancy

引用本文

引用格式 ▾
臧恬滋,韦仪,范肖肖,谢田瞿,刘燕群. 孕妇肠道菌群与产前抑郁之间的关联性及血浆色氨酸的潜在中介作用(英文)[J]. 中南大学学报(医学版), 2025, 50(12): 2226-2240 DOI:10.11817/j.issn.1672-7347.2025.250498

登录浏览全文

4963

注册一个新账户 忘记密码

Pregnant women inevitably experience uneasy emotions and depressive symptoms when they are about to face delivery in the third trimester of pregnancy. Prenatal depression is a psychological symptom characterized by a series of symptoms such as depression, crying, sadness, irritability, or suicide, prenatal depression is one of the most common mental disorders during pregnancy, with a global incidence of 20.7%[1]. It not only affects the health of pregnant women, but also causes many adverse health effects in the infant, such as intrauterine growth restriction, low birth weight, preterm birth, and cognitive-behavioral problems[2-3].
Although the pathogenesis of prenatal depression is currently unclear, multiple studies have demonstrated that unbalanced gut microbiota and disruption of the gut-brain axis (GBA), possibly via neural, endocrine, and immune pathways, influence brain function and behaviors that contribute to mental disorders[4-5], the way gut microbiota affects this may be related to changes in tryptophan metabolism, among other aspects. It has been found that pregnancy can lead to drastic alterations in the gut microbiota composition. During pregnancy, community richness decreases and community composition shows significant changes from early to late gestation, with an increase in lactate-producing bacteria, a decrease in butyrate-producing bacteria, and a significant reduction in the family Lachnospiraceae and genus Ruminococcus[6-7]. In animal experiments, it was found that stress was a predictor of gut microbiota changes during pregnancy. It decreased the β-diversity of gut microbiota, and members of the phylum Firmicutes and the order Clostridium (Lachnospiraceae and Ruminococcus) increased, paralleling a decrease in the phylum Bacteroidetes during late pregnancy in humans and animals[8]. Among pregnant women with prenatal depression, those with scores over 9 on the Edinburgh Postpartum Depression Scale (EPDS) in the second trimester had increased abundance of Faecalibacterium and decreased levels of Ruminococcus[9-10].
Regarding the GBA, 5-hydroxytryptamine (5-HT) is an important neurotransmitter in the central and peripheral nervous systems and is closely related to the occurrence and development of depression[11]. However, this neurotransmitter cannot cross the blood-brain barrier (BBB); the 5-HT found in the brain is mainly derived from metabolized tryptophan that has crossed the BBB[12]. The BBB, which consists of tightly junctional transmembrane proteins, tightly restricts the diffusion of water-soluble substances in the blood into the brain, such as 5-HT[13]. Since tryptophan can cross the BBB and promote 5-HT synthesis in the brain, it is suggested that tryptophan in the blood is a predictive factor of central nervous system dysregulations. Tryptophan is the only precursor of 5-HT, and when ingested in a sufficient amount, the amino acid concentration can be used to approximate the amount of 5-HT synthesis, which can directly impact the occurrence of depression[11]. During pregnancy, the activity of tryptophan catabolites (TRYCAT) pathway will change specifically, which may be related to hormonal changes and immune system, and whether it is related to gut microbiota during pregnancy has not been reported[14]. Several studies[12, 15] in animal models or human populations have suggested that the level of tryptophan in the blood may be controlled by the gut microbiota, either directly or indirectly, and the influence of microorganisms on tryptophan metabolism and the 5-HT system may be an important node in this regulation.
Although it was known that the gut microbiota was associated with depression, and tryptophan metabolism was one of the potential mechanisms, the way in which the gut microbiota during pregnancy affected gestational depression has not been fully elucidated. Most of the relevant studies have focused on postnatal depression, while there are relatively few empirical studies on the “gut microbiota-tryptophan-brain axis” in relation to prenatal depression. Furthermore, there is a paucity of research on how gut microbiota changes may be specifically mediated via tryptophan metabolism. Therefore, our study aimed to explore the impact of changes in the gut microbiota during pregnancy on the development of prenatal depression and to evaluate the mediating role of maternal plasma tryptophan in the 5-HT pathway of the GBA.

1 Materials and methods

1.1 Ethics statement

The study protocol was approved by the Medical Ethics Committee of School of Medicine of Wuhan University (2019YF2019). The participants agreed to join the study and signed informed consent.

1.2 Participant recruitment

This was a case-control study conducted in China. In total, we recruited 73 pregnant women in the third trimester of pregnancy from October 2020 to October 2021. Questionnaires, blood samples, and fecal samples were collected in the third trimester.

The inclusion criteria were as follows: 1) Over aged 20; 2) no pregnancy complications; 3) residence in the same place for a long time; and 4) self-reported no cognitive dysfunction. The exclusion criteria were as follows: 1) Self-reported smoking and alcohol abuse; 2) body mass index (BMI)≤30.0 kg/m2 before pregnancy; 3) history of mental illness before pregnancy; 4) a fever within the week prior to sample collection, 5) gastrointestinal symptoms (such as diarrhea, constipation, etc.) within one week prior to sample collection; 6) used medications within 30 days prior to sample collection that could affect the gut microbiota, such as probiotics, dilators, antibiotics and antivirals, etc.

1.3 Prenatal depression measurement

The EPDS is a self-report tool mainly used to screen for prenatal and postpartum depression[16-17]. The EPDS (Chinese Mainland version) had good reliability, the Cronbach’s alpha was 0.79[18]. The EPDS included 10 items, with a total score of 0 to 30 points. Higher scores indicate more severe depression. Participants with an EPDS score equal to or greater than 10 were assigned to a prenatal depression group, while those with an EPDS score less than 10 were assigned to a comparison group.

1.4 Fecal DNA extraction and sequencing

The gut microbiota was profiled using 16S ribosomal RNA (rRNA) sequence. Detailed protocols for DNA extraction, polymerase chain reaction (PCR) amplification, and 16S rRNA sequence have been described in previously published articles[19].

1.5 Plasma and fecal amino acid measurements

Each participant collected 5 mL venous blood by a professional nurse using a sodium citrate (anticoagulant 1꞉9) vacuum anticoagulant tube for determination of plasma amino acids. Samples were processed immediately after collection. After centrifugation, 200 µL/tube (2 tubes) of plasma was collected, labeled with the sample identifier as the participants’ plasma samples, and stored at -80 ℃. Fecal samples are also stored at -80 ℃. Repeated freezing and thawing were avoided.

A targeted ultrahigh performance liquid chromatography-electrospray ionization tandem mass spectrometry (UHPLC-ESI-MS/MS) method has been developed for the quantification of amino acid [20-21]. The experimental parameters were analyzed on an UHPLC-ESI-MS/MS system, consisting of a Shimadzu MS-8050 mass spectrometer (Kyoto, Japan) and an electrospray ionization source (Turbo Ion-spray), a Shimadzu LC-30AD UHPLC system (Kyoto, Japan), 230AD pumps, a SIL-30AC automatic sampler, a CTO-30A thermostatic column, and a DGU-20A5R degassing device.

1.6 Statistical analysis

The data was analyzed using SPSS 26.0 and R software. For general demographic characteristics analysis, the quantitative data were described with mean±standard deviation (M±SD), and qualitative data were described with frequency and percentage statistically. For gut microbiota analysis, the operational taxonomic unit (OTU) was flattened according to the minimum number of sample sequences to ensure the uniform distribution of gut microbiota. Core OTU analysis was used to analyze whether the sample size was sufficient. Community bar charts were used to depict the species composition of 2 groups of gut microbiota at the phylum and genus levels. The Wilcoxon rank-sum test was used to test for significant differences between 2 groups, to compare the species between the 2 groups at the genus level, and to obtain significantly different species between groups. The α-diversity measures of gut microbiota were used to determine the community richness and diversity of microbial communities. The principal co-ordinates analysis (PCoA) was performed using unweighted-UniFrac distance to determine the β-diversity of gut microbiota and compare the community composition between the 2 groups of samples. In addition, partial least squares discriminant analysis (PLS-DA) was also performed to compare gut microbiota composition between the 2 groups.

Comparisons of the α-diversity and amino acid measures between the 2 groups were performed using the independent samples t-test and the Wilcoxon rank-sum test. Spearman correlation analysis was performed: 1) Between plasma tryptophan and the top 200 most abundant species on genus level; 2) between the flattened OTU-normalized data for 2 groups of species that differ on the genus level and the EPDS scores. Simple linear regression was performed with plasma tryptophan concentration as the dependent variable for genera related to plasma tryptophan concentration. Binary Logistic regression was performed with gut microbiota that were different from the 2 groups. The mediation model was investigated by using model 4 in the PROCESS procedure for SPSS version 4.0.

2 Results

2.1 Demographic characteristics

There were 34 pregnant women in the prenatal depression group and 39 in the comparison group. All participants were married. Most of the pregnant women in the prenatal depression group (88.2%) and the comparison group (71.8%) had a bachelor’s degree or above. There were 31 (91.2%) women in the prenatal depression group and 35 (89.7%) women in the comparison group living in the city. Demographic information is listed in Table 1. Specific differences in the frequency of food consumption over a one-week timeframe between 2 groups are presented in Supplemental Table 1 (https://doi.org/10.57760/sciencedb. 36710).

The vast majority of pregnant women conceived naturally and had planned pregnancies, of which 32 (94.1%) from the prenatal depression group and 35 (89.7%) from the comparison group were naturally conceived, and 21 (61.8%) from the prenatal depression group and 30 (76.9%) from the comparison group had planned pregnancies. All were singleton pregnancies without abnormalities. Normality testing results of quantitative variables are presented in Supplemental Table 2 (https://doi. org/10.57760/sciencedb.36710).

2.2 Gut microbiota α- and β-diversity differences

The core OTU analysis meant the common number of OTUs decreased with the number of samples until flat, indicating the sequencing quantity was sufficient, shown in Supplemental Figure 1 (https://doi.org/10. 57760/sciencedb.36710) . The community richness of the comparison group was higher than that of the prenatal depression group as measured by Sobs (P=0.730), Chao (P=0.754), and Ace (P=0.820), but the community diversity of the prenatal depression group was higher, as indicated by Shannon (P=0.835) and Simpson (P=0.625), as well as coverage (P=0.673). Gut microbiota α-diversity was not significantly different between the 2 groups (P>0.05, Figure 1). Unweighted UniFrac PCoA on OTU level was used and indicated no obvious separation (r=0.008 6, P=0.271) between the 2 groups (Figure 2A). However, PLS-DA results showed the overall structures of maternal gut microbiota on OTU level were significantly different between the 2 groups (Figure 2B). In PCoA of the PC1 axis, the community composition of the prenatal depression group was more dispersed along the PC1 axis, and its β diversity was lower than that of the comparison group, although the difference was not statistically significant (P>0.05, Figure 2C).

2.3 Gut microbiota composition differences

At the phylum level, the community composition of the gut microbiota was the same phyla. The proportions of Firmicutes were 75.6% in the prenatal depression group and 73.5% in the comparison group, and the proportions of Actinobacteriota were 13.8% in the prenatal depression group and 14.8% in the comparison group (Figure 3A).

In the prenatal depression group, 18 genera accounted for over 1% of gut microbiota composition, while there were 23 genera in the comparison group. The dominant genera in both were Blautia, Faecalibacterium, and Bifidobacterium, which accounted for 14.6%, 13.1%, and 11.3% of the prenatal depression group, and 14.5%, 9.20% and 10.9% of the comparison group (Figure 3B).

On the genus level, Butyricicoccus and three genera (unclassified_f__Lachnospiraceae, Lachnospiraceae_UCG-001, and Lachnospiraceae_NC2004_group) belonging to family Lachnospiraceae were significantly more abundant in the prenatal depression group, while Enterococcus, Candidatus_Soleaferrea, and Prevotella were significantly more abundant in the comparison group (Figure 4).

2.4 Differences in plasma and fecal amino acids concentration

In the comparison group, the concentration of plasma serine was higher than in those with prenatal depression. The concentration of plasma 5-HT (t=2.070, P=0.042) and tryptophan (t=-2.964, P=0.004) was significantly different between the 2 groups (Figure 5). There was no significant difference in the TRP/KYN between the prenatal depression group and the comparison group (0.088±0.025 vs 0.079±0.016, P>0.05). For fecal amino acids concentrations, the concentration of kynurenine was not detected in 2 groups, and there was no difference in the fecal amino acid concentrations between 2 groups (P>0.05, Table 2).

2.5 Relationship between maternal gut microbiota and plasma tryptophan

Butyricimonas, Subdoligranulum, Faecalibacterium, and other 10 genera had a positive correlation relationship with tryptophan, while Enterococcus, Escherichia-Shigella, [Ruminococcus]_gnavus_group, and Erysipelatoclostridium were negatively correlated with tryptophan (all P<0.05, Figure 6). Using plasma tryptophan concentration as the dependent variable, simple linear regression was performed on tryptophan concentration-related genera. Significance was only found in the negative correlation between [Ruminococcus]_gnavus_group (β=-246.942, 95% CI -402.491 to -91.392), Enterococcus (β=-331.150, 95% CI -544.617 to -117.684) and tryptophan (both P<0.05, Table 3).

2.6 Mediating effect of plasma tryptophan between maternal gut microbiota and prenatal depression

Correlation heatmap was performed between the genera differentially expressed in 2 groups and EPDS scores (Figure 6). We find that Lachnospiraceae_NC2004_group (β=5.870, OR=354.354, 95% CI 1.24 895 to 100 619.527, P=0.042) was higher in the prenatal depression group, and Candidatus_Soleaferrea (β=-19.945, OR<0.001, 95% CI <0.001 to 0.002, P=0.004) and Enterococcus (β=-9.074, OR<0.001, 95% CI <0.001 to 0.183, P=0.016) were higher in the comparison group (Table 4). Enterococcus was the only gut microbiota related to plasma tryptophan concentration and prenatal depression after controlling covariates. The mediation effect model showed that plasma tryptophan played a partially intermediate role between maternal gut microbiota and prenatal depression (Figure 7 and Table 5). The detailed results obtained by model 4 are shown in Supplemental Table 3 (https://doi.org/10. 57760/sciencedb.36710).

3 Discussion

This study explored the mediating role of tryptophan in the relationship between prenatal depression and maternal gut microbiota. We found that the abundances of Candidatus_Soleaferrea and Enterococcus were negatively correlated with prenatal depression, while the abundance of Lachnospiraceae_NC2004_group was positively correlated with prenatal depression. We also discovered a significant difference in plasma tryptophan in pregnant women between the 2 groups. Therefore, it is plausible that plasma tryptophan was a key component in the GBA 5-HT pathway affecting the occurrence of prenatal depression.

Maternal gut microbiota changes dramatically during pregnancy. The GBA theory holds that the composition of the gut microbiota is closely related to negative emotions such as anxiety and depression. The α- and β-diversity can measure the richness and evenness of gut microbiota, and can reflect the stability of gut microbiota. There was no significant difference in the α- and β-diversity of gut microbiota between the prenatal depression group and the comparison group, which was consistent with previous studies[19, 22-23]. Although the diversity of most studies has remained the same, changes in the abundance of specific bacterial genera may also affect the occurrence of prenatal depression.

Our results indicated there were significant differences in the abundance of Butyricicoccus, Enterococcus, Lachnospiraceae_NC2004_group, Family_XIII_UCG-001, and Candidatus_Soleaferrea between the prenatal depression group and the comparison group. Consistent with our findings, previous studies[24-25] found that those with depression symptoms had higher abundance of the family Lachnospiraceae and genus Candidatus_Soleaferrea, and lower abundance of the Enterococcus compared with those without depression symptoms. The significant differences we found in Butyricicoccus and Family_XIII_UCG-001 were consistent with previous findings[26] in mouse models. In addition to increased chronic social defeat stress that induced depressive behavior, higher abundance of Family_XIII_UCG-001 was also associated with more serious depression-like behavior[27].

Since the reduced availability of 5-HT in the brain was a key feature of depression incidence, it can be posited that tryptophan as the sole precursor of 5-HT, plays a significant role in the development of depression[15, 28]. It was found that 5-HT in blood had an effect on emotional and psychological stress, as the level of 5-HT in the central nervous system of depressed patients was less than that of non-depressed patients[29]. This study has revealed the decrease of plasma 5-HT was associated with an increased risk of prenatal depression, but 5-HT did not show a mediating or regulatory effect between the gut microbiota and prenatal depression[30]. We found that plasma tryptophan concentration in those with prenatal depression was significantly different from comparison group, with plasma tryptophan, kynurenine and KYN/TRP higher in the prenatal depression group. Previous study[31] have shown that the tryptophan concentration in the participants with current major depressive disorder was higher than that in the control group, which was consistent with our research results. A possible explanation is that in the tryptophan metabolic pathway, conversion to 5-HT was inhibited, leading to increased indoleamine-2,3-dioxygenase (IDO) activity, while conversion to kynurenine was enhanced. Therefore, physiological changes that lead to altered tryptophan metabolism may lead to the occurrence of depression[32-34]. In addition, this study also demonstrated the association between the concentration of plasma tryptophan and the abundance of Enterococcus. Prior research[35] has indicated that the abundance of Enterococcus can influence the metabolism of tryptophan, consistent with our results. Gut microbiota can directly utilize tryptophan, potentially limiting the tryptophan’s bioavailability, reducing the production of 5-HT, and gut microbiota also can indirectly impact the metabolism of tryptophan in blood by disrupting the activity of IDO, thus affecting the downstream synthesis of 5-HT[15, 36].

This study revealed that Enterococcus was enriched in the comparison group, and tryptophan was a mediator between Enterococcus and prenatal depression symptoms. Moreover, the concentration of plasma tryptophan was positively related to the abundance of Enterococcus, consistent with prior animal studies[35, 37-38]. Enterococcus faecalis prevented colitis-induced depressive-like behavior through the GBA in mice[39]. Intervention with probiotics (Bifidobacterium, Lactobacillus, Enterococcus and Bacillus cereus) can also alleviate depressive symptoms[40]. Enterococcus has been shown to affect depressive behavior in the brain-gut axis through the inflammatory pathway[40-43]. A previous publication[44] suggests a potential mechanistic framework, reporting a significant three-way interaction between prenatal tryptophan levels, IL-6, and EPDS scores. Thus, the mechanism by which Enterococcus affects prenatal depression may be through its effect on inflammatory factors, thereby changing tryptophan metabolism and ultimately affecting 5-HT production. According to the monoamine hypothesis, 5-HT is one of the major neurotransmitters in depression, and there is a significant decrease in 5-HT levels in depressed individuals[45].

This study also found that Candidatus_Soleaferrea was enriched in the comparison group, while Lachnospiraceae_NC2004_group was enriched in the prenatal depression group. Candidatus_Soleaferrea belongs to the family Ruminococcaceae. In an animal model, supplementation with Enterococcus altered gut microbial composition by increasing the abundance of Candidatus_Soleaferrea[35]. There is evidence to suggest that the family Ruminococcaceae is related to tryptophan metabolism and depression, concurrent with the improvement of depression symptoms, the concentration of tryptophan decreased while the abundance of Ruminococcaceae increased[46]. Lachnospiraceae_NC2004_group belongs to the family Lachnospiraceae. Prior study[47] had linked the family Lachnospiraceae to depression. As there are few studies on these genera, the role of Candidatus_Soleaferrea and Lachnospiraceae_NC2004_group in prenatal depression can be investigated further.

We explored the potential association between “gut microbiota-tryptophan- prenatal depression” in the Chinese pregnant women and found that the specific genus, such as Enterococcus and Candidatus_Soleaferrea had a protective effect against prenatal depression. There are several limitations in our study. Firstly, although we used a self-made 10-item diet scale to investigate diet, diet as one of the important factors affecting gut microbiota, still needed to be carefully considered. Secondly, all the participants were highly educated pregnant women from the same region, and some of the research data were self-reported, which may lead to certain selection bias and information bias. In addition, shotgun metagenomic sequencing is more capable of analyzing the complex composition and functions of gut microbiota. Compared with shotgun metagenomic sequencing, the 16S rRNA sequence has some limitations. Blood and fecal samples were only collected in the third trimester of pregnancy, making it difficult to detect the changes in the gut microbiota and plasma tryptophan throughout pregnancy. Although demographic and dietary factors that could cause confounding were controlled, endocrine indicators (such as hormone levels) and psychological-social factors (such as stress, family support, etc.) that might have an impact were not included and analyzed. These variables will be included in the consideration of covariates in future research. Finally, the small sample size resulted in limited generalizability.

In summary, prenatal depression is related to plasma tryptophan concentration. The abundances of Candidatus_Soleaferrea and Enterococcus were negatively associated with prenatal depression, while the abundance of Lachnospiraceae_NC2004_group was positively associated with prenatal depression.

参考文献

[1]

Yin X, Sun N, Jiang N, et al. Prevalence and associated factors of antenatal depression: Systematic reviews and meta-analyses[J]. Clin Psychol Rev, 2021, 83: 101932.

[2]

Ghimire U, Papabathini SS, Kawuki J, et al. Depression during pregnancy and the risk of low birth weight, preterm birth and intrauterine growth restriction- an updated meta-analysis[J]. Early Hum Dev, 2021, 152: 105243.

[3]

Prado EL, Sebayang SK, Adawiyah SR, et al. Maternal depression is the predominant persistent risk for child cognitive and social-emotional problems from early childhood to pre-adolescence: a longitudinal cohort study[J]. Soc Sci Med, 2021, 289: 114396.

[4]

Liang S, Wu X, Hu X, et al. Recognizing depression from the microbiota-gut-brain axis[J]. Int J Mol Sci, 2018, 19(6): 1592.

[5]

Westfall S, Caracci F, Estill M, et al. Chronic stress-induced depression and anxiety priming modulated by gut-brain-axis immunity[J]. Front Immunol, 2021, 12: 670500.

[6]

Di Simone N, Santamaria Ortiz A, Specchia M, et al. Recent insights on the maternal microbiota: impact on pregnancy outcomes[J]. Front Immunol, 2020, 11: 528202.

[7]

Tang M, Weaver NE, Frank DN, et al. Longitudinal reduction in diversity of maternal gut microbiota during pregnancy is observed in multiple low-resource settings: results from the women first trial[J]. Front Microbiol, 2022, 13: 823757.

[8]

Rackers HS, Thomas S, Williamson K, et al. Emerging literature in the microbiota-brain axis and perinatal mood and anxiety disorders[J]. Psychoneuroendocrinology, 2018, 95: 86-96.

[9]

Qiu W, Hodges TE, Clark EL, et al. Perinatal depression: Heterogeneity of disease and in animal models[J]. Front Neuroendocrinol, 2020, 59: 100854.

[10]

Peñalver Bernabé B, Maki PM, Dowty SM, et al. Precision medicine in perinatal depression in light of the human microbiome[J]. Psychopharmacology, 2020, 237(4): 915-941.

[11]

Cervenka I, Agudelo LZ, Ruas JL. Kynurenines: Tryptophan’s metabolites in exercise, inflammation, and mental health[J/OL]. Science, 2017, 357(6349): eaaf9794[2025-01-12].

[12]

Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease[J]. Cell Host Microbe, 2018, 23(6): 716-724.

[13]

Waclawiková B, El Aidy S. Role of microbiota and tryptophan metabolites in the remote effect of intestinal inflammation on brain and depression[J]. Pharmaceuticals, 2018, 11(3): 63.

[14]

Roomruangwong C, Anderson G, Berk M, et al. A neuro-immune, neuro-oxidative and neuro-nitrosative model of prenatal and postpartum depression[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2018, 81: 262-274.

[15]

Gao K, Mu CL, Farzi A, et al. Tryptophan metabolism: a link between the gut microbiota and brain[J]. Adv Nutr, 2020, 11(3): 709-723.

[16]

Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. development of the 10-item Edinburgh postnatal depression scale[J]. Br J Psychiatry, 1987, 150: 782-786.

[17]

Zhang L, Wang L, Cui S, et al. Prenatal depression in women in the third trimester: prevalence, predictive factors, and relationship with maternal-fetal attachment[J]. Front Public Health, 2020, 8: 602005.

[18]

Wang Y, Guo X, Lau Y, et al. Psychometric evaluation of the mainland Chinese version of the Edinburgh postnatal depression scale[J]. Int J Nurs Stud, 2009, 46(6): 813-823.

[19]

Fang Q, Tu Y, Fan X, et al. Inflammatory cytokines and prenatal depression: Is there a mediating role of maternal gut microbiota?[J]. J Psychiatr Res, 2023, 164: 458-467.

[20]

Sadok I, Jędruchniewicz K, Rawicz-Pruszyński K, et al. UHPLC-ESI-MS/MS quantification of relevant substrates and metabolites of the kynurenine pathway present in serum and peritoneal fluid from gastric cancer patients-method development and validation[J]. Int J Mol Sci, 2021, 22(13): 6972.

[21]

Whiley L, Nye LC, Grant I, et al. Ultrahigh-performance liquid chromatography tandem mass spectrometry with electrospray ionization quantification of tryptophan metabolites and markers of gut health in serum and plasma-application to clinical and epidemiology cohorts[J]. Anal Chem, 2019, 91(8): 5207-5216.

[22]

Nel NH, Marafie A, Bassis CM, et al. Edinburgh postpartum depression scores are associated with vaginal and gut microbiota in pregnancy[J]. J Affect Disord, 2025, 371: 22-35.

[23]

Zhou YM, Chen C, Yu HB, et al. Fecal microbiota changes in patients with postpartum depressive disorder[J]. Front Cell Infect Microbiol, 2020, 10: 567268.

[24]

Simpson CA, Diaz-Arteche C, Eliby D, et al. The gut microbiota in anxiety and depression-A systematic review[J]. Clin Psychol Rev, 2021, 83: 101943.

[25]

Nikolova VL, Smith MRB, Hall LJ, et al. Perturbations in gut microbiota composition in psychiatric disorders: a review and meta-analysis[J]. JAMA Psychiatry, 2021, 78(12): 1343-1354.

[26]

Luo X, Huang X, Luo Z, et al. Electromagnetic field exposure-induced depression features could be alleviated by heat acclimation based on remodeling the gut microbiota[J]. Ecotoxicol Environ Saf, 2021, 228: 112980.

[27]

Tian T, Xu B, Qin Y, et al. Clostridium butyricum miyairi 588 has preventive effects on chronic social defeat stress-induced depressive-like behaviour and modulates microglial activation in mice[J]. Biochem Biophys Res Commun, 2019, 516(2): 430-436.

[28]

Lin S, Li Q, Xu Z, et al. Detection of the role of intestinal flora and tryptophan metabolism involved in antidepressant-like actions of crocetin based on a multi-omics approach[J]. Psychopharmacology, 2022, 239(11): 3657-3677.

[29]

Hamon M, Blier P. Monoamine neurocircuitry in depression and strategies for new treatments[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2013, 45: 54-63.

[30]

Xie T, Fan X, Pang H, et al. Association between gut microbiota and its functional metabolites with prenatal depression in women[J]. Neurobiol Stress, 2023, 28: 100592.

[31]

Milaneschi Y, Allers KA, Beekman ATF, et al. The association between plasma tryptophan catabolites and depression: The role of symptom profiles and inflammation[J]. Brain Behav Immun, 2021, 97: 167-175.

[32]

Wang Y, Cai X, Ma Y, et al. Metabolomics on depression: a comparison of clinical and animal research[J]. J Affect Disord, 2024, 349: 559-568.

[33]

Wu RY, Xiao K, Hotte N, et al. Elevated IL-6 and IL-22 in early pregnancy are associated with worse disease course in women with inflammatory bowel disease[J]. Int J Mol Sci, 2022, 23(18): 10281.

[34]

杜静, 黎娇, 刘朴乐, . 肠道菌群基于色氨酸代谢通路调控抑郁障碍的机制[J]. 中南大学学报(医学版), 2025, 50(7): 1263-1270.

[35]

DU Jing, LI Jiao, LIU Pule, et al. Mechanisms by which the gut microbiota regulates depressive disorder via the tryptophan metabolic pathway[J]. Journal of Central South University. Medical Science, 2025, 50(7): 1263-1270.

[36]

Huang S, Rong X, Liu M, et al. Intestinal mucosal immunity-mediated modulation of the gut microbiome by oral delivery of Enterococcus faecium against Salmonella Enteritidis pathogenesis in a laying hen model[J]. Front Immunol, 2022, 13: 853954.

[37]

Gao K, Pi Y, Mu CL, et al. Increasing carbohydrate availability in the hindgut promotes hypothalamic neurotransmitter synthesis: aromatic amino acids linking the microbiota-brain axis[J]. J Neurochem, 2019, 149(5): 641-659.

[38]

Wei Z, Zhou N, Zou L, et al. Soy protein alleviates malnutrition in weaning rats by regulating gut microbiota composition and serum metabolites[J]. Front Nutr, 2021, 8: 774203.

[39]

Yusufu I, Ding K, Smith K, et al. A tryptophan-deficient diet induces gut microbiota dysbiosis and increases systemic inflammation in aged mice[J]. Int J Mol Sci, 2021, 22(9): 5005.

[40]

Takahashi K, Kurokawa K, Hong L, et al. Antidepressant effects of Enterococcus faecalis 2001 through the regulation of prefrontal cortical myelination via the enhancement of CREB/BDNF and NF-κB p65/LIF/STAT3 pathways in olfactory bulbectomized mice[J]. J Psychiatr Res, 2022, 148: 137-148.

[41]

Wang Y, Zhang X, Wang Y, et al. Effects of combined live Bifidobacterium, Lactobacillus, Enterococcus and Bacillus cereus Tablets on post-stroke depression and serum inflammatory factorse[J]. Discov Med, 2023, 35(176): 312-320.

[42]

Yuan X, Chen B, Duan Z, et al. Depression and anxiety in patients with active ulcerative colitis: crosstalk of gut microbiota, metabolomics and proteomics[J]. Gut Microbes, 2021, 13(1): 1987779.

[43]

Jang HM, Kim JK, Joo MK, et al. Enterococcus faecium and Pediococcus acidilactici deteriorate Enterobacteriaceae-induced depression and colitis in mice[J]. Sci Rep, 2022, 12(1): 9389.

[44]

Takahashi K, Nakagawasai O, Nemoto W, et al. Effect of Enterococcus faecalis 2001 on colitis and depressive-like behavior in dextran sulfate sodium-treated mice: involvement of the brain-gut axis[J]. J Neuroinflammation, 2019, 16(1): 201.

[45]

Nazzari S, Molteni M, Valtorta F, et al. Prenatal IL-6 levels and activation of the tryptophan to kynurenine pathway are associated with depressive but not anxiety symptoms across the perinatal and the post-partum period in a low-risk sample[J]. Brain Behav Immun, 2020, 89: 175-183.

[46]

Bhatt S, Devadoss T, Manjula SN, et al. 5-HT(3) receptor antagonism a potential therapeutic approach for the treatment of depression and other disorders[J]. Curr Neuropharmacol, 2021, 19(9): 1545-1559.

[47]

Cheng D, Chang H, Ma S, et al. Tiansi liquid modulates gut microbiota composition and tryptophan-kynurenine metabolism in rats with hydrocortisone-induced depression[J]. Molecules, 2018, 23(11): 2832.

[48]

Cheung SG, Goldenthal AR, Uhlemann AC, et al. Systematic review of gut microbiota and major depression[J]. Front Psychiatry, 2019, 10: 34.

基金资助

the National Natural Science Foundation of China(81903334)

the National Natural Science Foundation of China(82473647)

RIGHTS & PERMISSIONS

©Journal of Central South University (Medical Science). All rights reserved.

AI Summary AI Mindmap
PDF (2871KB)

290

访问

0

被引

详细

导航
相关文章

AI思维导图

/